Siren Biotechnology and RISE Robotics Triumph at Superpowers for Good Live Pitch Q2 2025
Siren Biotechnology and RISE Robotics were recognized for their innovative contributions to cancer treatment and energy-efficient industrial motion systems at the Superpowers for Good Live Pitch, highlighting the event's role in fostering impactful entrepreneurship.
Siren Biotechnology and RISE Robotics emerged as the standout winners at the Superpowers for Good Live Pitch Q2 2025, a testament to their groundbreaking work in biotechnology and industrial motion systems. Dr. Nicole Paulk, CEO of Siren Biotechnology, received the SuperCrowd Award for her company's novel cancer therapies, while Hiten Sonpal, CEO of RISE Robotics, was honored with the Judges' Choice Award for his company's energy-efficient solutions.
The event, hosted by Devin Thorpe of The Super Crowd, Inc., showcased four founders presenting their Regulation Crowdfunding campaigns. Siren Biotechnology's approach to cancer treatment and RISE Robotics' innovation in reducing energy consumption and emissions in heavy machinery were particularly noted for their potential to drive significant social and environmental impact.
Winners were awarded a comprehensive package of prizes aimed at supporting their growth, including marketing strategy consultations and tools for investor intelligence. The Superpowers for Good Live Pitch continues to serve as a pivotal platform for entrepreneurs committed to making a difference, with the next event scheduled for late September 2025.